Ionis Pharmaceuticals (IONS)
(Delayed Data from NSDQ)
$47.68 USD
-2.22 (-4.45%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $47.69 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | -1.17 |
EPS Last Quarter | -0.45 |
Last EPS Surprise | 52.63% |
ABR | 1.86 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.69 |
Next Year | -3.61 |
EPS (TTM) | -2.52 |
P/E (F1) | NA |
% EPS Growth Estimates | IONS | IND | S&P |
---|---|---|---|
Current Qtr (09/2024) | -13.59 | -1,600.56 | 11.23 |
Next Qtr (12/2024) | -1,733.33 | -335.90 | 20.57 |
Current Year (12/2024) | -44.14 | 20.20 | 15.67 |
Next Year (12/2025) | 2.17 | 15.20 | 11.34 |
Past 5 Years | -207.80 | 7.90 | 8.10 |
Next 5 Years | 8.40 | 21.70 | NA |
PE | NA | -1.60 | 22.87 |
PEG Ratio | NA | -0.07 | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 130.88M | 154.62M | 625.72M | 726.31M |
# of Estimates | 9 | 9 | 9 | 9 |
High Estimate | 145.90M | 200.80M | 690.80M | 875.01M |
Low Estimate | 113.20M | 128.00M | 598.00M | 648.50M |
Year ago Sales | 144.00M | 325.00M | 788.00M | 625.72M |
Year over Year Growth Est. | -9.11% | -52.43% | -20.59% | 16.08% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.17 | -1.10 | -3.69 | -3.61 |
# of Estimates | 9 | 8 | 10 | 10 |
Most Recent Consensus | -1.23 | -1.17 | -3.84 | -3.91 |
High Estimate | -0.96 | -0.62 | -3.05 | -2.66 |
Low Estimate | -1.31 | -1.27 | -4.04 | -5.04 |
Year ago EPS | -1.03 | -0.06 | -2.56 | -3.69 |
Year over Year Growth Est. | -13.59% | -1,733.33% | -44.14% | 2.14% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 1 | 0 |
Up Last 30 Days | 0 | 2 | 8 | 2 |
Up Last 60 Days | 1 | 2 | 8 | 3 |
Down Last 7 Days | 1 | 1 | 0 | 1 |
Down Last 30 Days | 8 | 6 | 2 | 7 |
Down Last 60 Days | 6 | 6 | 2 | 7 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.17 | -1.10 | -3.69 | -3.61 |
7 Days Ago | -1.16 | -1.07 | -3.73 | -3.61 |
30 Days Ago | -1.00 | -0.93 | -3.90 | -3.42 |
60 Days Ago | -1.03 | -0.96 | -3.93 | -3.38 |
90 Days Ago | -1.04 | -0.98 | -3.98 | -3.44 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.17 | -1.10 | -3.69 | -3.54 |
Zacks Consensus Estimate | -1.17 | -1.10 | -3.69 | -3.61 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 2.06% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.45 | -0.98 | -0.06 | -1.03 | NA |
Estimate | -0.95 | -1.10 | -0.78 | -1.01 | NA |
Difference | 0.50 | 0.12 | 0.72 | -0.02 | 0.33 |
Surprise | 52.63% | 10.91% | 92.31% | -1.98% | 38.47% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more